Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 3,743 shares at $14.64 ($52K) on 2025-08-13, disclosed to the SEC on 2025-08-14.
Scheduled sale ($52k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.58 | 2,937 | $40K | 77.2% |
| 2 | $14.64 | 806 | $12K | 22.8% |
| Total | $13.81 avg | 3,743 | $52K | 100% |
| Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |
| DNLI | SELL | 2024-01-12 | $178K | — | Filing → |